Cargando…

Pharmacogenetics of SGLT2 Inhibitors: Validation of a sex-agnostic pharmacodynamic biomarker

AIM: SGLT2 inhibitors provide multiple benefits to patients with type 2 diabetes – including improved glycemic control and decreased risks of cardiorenal disease. Because drug responses vary among individuals, we initiated investigations to identify genetic variants associated with the magnitude of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taylor, Simeon I., Cherng, Hua-Ren, Yazdi, Zhinous Shahidzadeh, Montasser, May E., Whitlatch, Hilary B., Mitchell, Braxton D., Shuldiner, Alan R., Streeten, Elizabeth A., Beitelshees, Amber L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029014/ https://www.ncbi.nlm.nih.gov/pubmed/36945579 http://dx.doi.org/10.1101/2023.03.07.23286875

Ejemplares similares

Acute pharmacodynamic responses to sitagliptin: Drug-induced increase in early insulin secretion in oral glucose tolerance test
por: Beitelshees, Amber L., et al.
Publicado: (2023)

Vitamin D deficiency increases vulnerability to canagliflozin-induced adverse effects on 1,25-dihydroxyvitamin D and PTH
por: Yazdi, Zhinous Shahidzadeh, et al.
Publicado: (2023)

Acute pharmacodynamic responses to exenatide: Drug-induced increases in insulin secretion and glucose effectiveness
por: Taylor, Simeon I., et al.
Publicado: (2023)

THU397 Homeostatic Regulation Of 1,25-dihydroxyvitamin D: Critical Role Of 24-hydroxylation (CYP24A1)
por: Yazdi, Zhinoosossadat Shahidzadeh, et al.
Publicado: (2023)

Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen
por: de Vries Schultink, Aurelia H. M., et al.
Publicado: (2015)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
por: Brunet, Mercè, et al.
Publicado: (2022)

Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update
por: Teng, Renli
Publicado: (2015)

Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation
por: Yu, Meng, et al.
Publicado: (2018)

Zinc–rs13266634 and the Arrival of Diabetes Pharmacogenetics: The “Zinc Mystique”
por: Maruthur, Nisa M., et al.
Publicado: (2014)

Clinical impact of recent genetic discoveries in osteoporosis
por: Mitchell, Braxton D, et al.
Publicado: (2013)

Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy
por: Alvitigala, Bhawani Yasassri, et al.
Publicado: (2020)

Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
por: de Man, Femke M., et al.
Publicado: (2018)

The Bacillus Agnostic
Publicado: (1911)

Proton Pump Inhibitors in Pediatrics: Mechanism of Action, Pharmacokinetics, Pharmacogenetics, and Pharmacodynamics
por: Ward, Robert M., et al.
Publicado: (2013)

The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review
por: Yalçin, Nadir, et al.
Publicado: (2022)

Individualization of Mycophenolic Acid Therapy through Pharmacogenetic, Pharmacokinetic and Pharmacodynamic Testing
por: Winnicki, Wolfgang, et al.
Publicado: (2022)

Agnostic Tendency in Doctors
Publicado: (1885)

Population Pharmacokinetic, Pharmacogenetic, and Pharmacodynamic Analysis of Cyclophosphamide in Ethiopian Breast Cancer Patients
por: Ahmed, Jemal Hussien, et al.
Publicado: (2020)

Sodium–Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research
por: Beitelshees, Amber L., et al.
Publicado: (2019)

Homozygosity by descent mapping of blood pressure in the Old Order Amish: evidence for sex specific genetic architecture
por: McArdle, Patrick F, et al.
Publicado: (2007)

Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib‐Treated Cancer
por: Diekstra, MH, et al.
Publicado: (2017)

Tumour-agnostic drugs in paediatric cancers
por: Chisholm, Julia C., et al.
Publicado: (2020)

Drug Development in Tissue-Agnostic Indications
por: du Rusquec, Pauline, et al.
Publicado: (2021)

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting
por: Cavallari, LH, et al.
Publicado: (2017)

Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses
por: Anthoney, D Alan, et al.
Publicado: (2012)

KCNQ1 and Long QT Syndrome in 1/45 Amish: The Road From Identification to Implementation of Culturally Appropriate Precision Medicine
por: Streeten, Elizabeth A., et al.
Publicado: (2020)

Source-Agnostic Gravitational-Wave Detection with Transformers
por: Debru, Natnael Berhane
Publicado: (2022)

Polarization- and wavelength-agnostic nanophotonic beam splitter
por: González-Andrade, David, et al.
Publicado: (2019)

Reference-agnostic representation and visualization of pan-genomes
por: Liang, Qihua, et al.
Publicado: (2021)

Technology agnostic frequency characterization methodology for memristors
por: Manouras, Vasileios, et al.
Publicado: (2021)

Model agnostic generation of counterfactual explanations for molecules
por: Wellawatte, Geemi P., et al.
Publicado: (2022)

Crop Agnostic Monitoring Driven by Deep Learning
por: Halstead, Michael, et al.
Publicado: (2021)

Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer
por: Loupakis, F, et al.
Publicado: (2011)

MON-500 A Case of Tumor-Induced Osteomalacia Caused by Metastatic Prostate Cancer
por: Rahman, Wedad, et al.
Publicado: (2019)

SAT245 Hips Don’t Lie: A Case Of Peri-Prosthetic Pseudotumor Leading To Hypercalcemia After Total Hip Replacement.
por: Sotomayor, Fiorella, et al.
Publicado: (2023)

An Amish founder population reveals rare-population genetic determinants of the human lipidome
por: Montasser, May E., et al.
Publicado: (2022)

Multi-site investigation of strategies for the clinical implementation of preemptive pharmacogenetic testing
por: Duarte, Julio D., et al.
Publicado: (2021)

New Physics Agnostic Selections For New Physics Searches
por: Woźniak, Kinga Anna, et al.
Publicado: (2020)

Source-Agnostic Gravitational-Wave Detection with Recurrent Autoencoders
por: Moreno, Eric A., et al.
Publicado: (2021)

Quantifying Antibody Responses Induced by Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ip5tcpin35cko2mmfvre0mn5uu